BIOMARKER DER IL7R-MODULATORAKTIVITÄT

Patent europeic · EP4499875 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4499875
Numer da la dumonda
EP23729398
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
30-05-2023
Publitgà
05-02-2025
Concedì
12-03-2025
La protecziun finescha il pli tard
29-05-2043
Proxima taxa annuala scadenta
31-05-2026
Classas IPC
C12Q 1/6883 (2018.01)
C12Q 1/6886 (2018.01)
Prioritad
EP 22305790 30.05.2022
Dumonda PCT
PCT/EP2023/064461 30.05.2023
Publicaziun PCT
WO2023/232826 07.12.2023
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-01-2026

    Midada

    Published in Swissreg on 21.01.2026

  2. 12-03-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 12.03.2025

Partidas

Possessur

OSE Immunotherapeutics

OSE IMMUNOTHERAPEUTICS

22, boulevard Benoni Goullin, 44200 Nantes, FR

Inventur

POIRIER, Nicolas

44119 GRANDCHAMPS DES FONTAINES, FR

GIRAULT, Isabelle

44000 NANTES, FR

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.